SCHEMBL30765616

SCHEMBL30765616

CCCCOC(=O)Cn1c(N2CCCCC2)ncc(N[C@H](C)c2coc(-c3ccccc3F)n2)c1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.37
ALDH1A1 P00352 6/20 0.37
TSHR P16473 4/20 0.35
NPSR1 Q6W5P4 4/20 0.35
MAPK1 P28482 3/20 0.35
HSD17B10 Q99714 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
KDM4E B2RXH2 2/20 0.35
GAA P10253 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
POLB P06746 1/20 0.33
NPC1 O15118 1/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
NFKB1 P19838 1/20 0.32
RAB9A P51151 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31558527 0.67 AKT1 (0.36) LMNAALDH1A1TSHRNPSR1MAPK1
SCHEMBL31558437 0.65 AKT1 (0.35) ALDH1A1TSHRSMN1; SMN2KDM4EL3MBTL1
SCHEMBL31558496 0.61 IDH1 (0.37) ALDH1A1NPSR1SMN1; SMN2KDM4EKMT2A
SCHEMBL31558557 0.61 POLB (0.37) LMNAALDH1A1NPSR1MAPK1SMN1; SMN2
SCHEMBL6649823 0.58 MEN1 (0.44) LMNAALDH1A1TSHRNPSR1MAPK1
SCHEMBL31558470 0.56 LMNA (0.37) LMNAALDH1A1NPSR1SMN1; SMN2KDM4E
SCHEMBL20356854 0.55 MEN1 (0.52) LMNAALDH1A1TSHRNPSR1MAPK1
SCHEMBL521967 0.55 ALDH1A1 (0.83) LMNAALDH1A1NPSR1L3MBTL1KMT2A
SCHEMBL11464739 0.55 GRIA4 (0.42) ALDH1A1TSHRNPSR1L3MBTL1KMT2A
SCHEMBL31558502 0.54 NOTUM (0.34) LMNAALDH1A1MAPK1HSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4568666-A1 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS Alexion Pharmaceuticals, Inc. (US) 2025-06-18 EP disclosed
WO-2024035686-A1 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS ALEXION PHARMACEUTICALS, INC. (US) 2024-02-15 WO disclosed